Overview

A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or Cannabidiol

Status:
Terminated

Trial end date:
2020-05-22

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the pharmacodynamic (PD) interaction between steady-steady treatment with padsevonil (PSL) and Ethanol and the pharmacokinetic (PK) interaction between stead-state treatment with PSL and cannabidiol (CBD).

Phase:

Phase 1

Details

Lead Sponsor:

UCB Biopharma S.P.R.L.

Treatments:

Epidiolex
Ethanol